Literature DB >> 14563163

Effect of 14-membered macrolide compounds on monocyte to macrophage differentiation.

Toshiaki Sunazuka1, Kiminari Yoshida, Masako Oohori, Kazuhiko Otoguro, Yoshihiro Harigaya, Yuzuru Iwai, Kiyoko S Akagawa, Satoshi Omura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14563163     DOI： 10.7164/antibiotics.56.721

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

1.  Macrolides Inhibit Capsule Formation of Highly Virulent Cryptococcus gattii and Promote Innate Immune Susceptibility.

Authors:  Shigeki Nakamura; Yurika Ikeda-Dantsuji; Lianjin Jin; Yoshitsugu Higashi; Masahiro Abe; Tatsuya Inukai; Minoru Nagi; Makoto Urai; Yoshitsugu Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 2.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPbeta.

Authors:  Iwao Komuro; Toshiaki Sunazuka; Kiyoko S Akagawa; Yasuko Yokota; Aikichi Iwamoto; Satoshi Omura
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

4.  Suppression of nitric oxide production from nasal fibroblasts by metabolized clarithromycin in vitro.

Authors:  Ayako Furuya; Kazuhito Asano; Naruo Shoji; Kojiro Hirano; Taisuke Hamasaki; Harumi Suzaki
Journal:  J Inflamm (Lond)       Date:  2010-11-23       Impact factor: 4.981

5.  COVID-19 in solid organ transplant recipients: a single-center experience.

Authors:  Rogier A S Hoek; Olivier C Manintveld; Michiel G H Betjes; Merel E Hellemons; Leonard Seghers; Jeroen A A Van Kampen; Kadir Caliskan; Jacqueline van de Wetering; Martijn van den Hoogen; Herold J Metselaar; Dennis A Hesselink
Journal:  Transpl Int       Date:  2020-06-26       Impact factor: 3.842
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.